Magnetic resonance and nuclear imaging of the right ventricle in pulmonary arterial hypertension

European Heart Journal, Supplement

Volumn 9, Issue H, 2007, Pages

  Vonk Noordegraaf, Anton ^a   Lankhaar, Jan Willem ^a   Götte, Marco J W ^a   Marcus, J Tim ^a   Postmus, Pieter E ^a   Westerhof, Nico ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Delayed contrast enhancement; Perfusion; PET; SPECT; Ventricular function; Ventricular structure

Indexed keywords

EID: 77949403880     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sum026     Document Type: Article

References (49)

1. Roeleveld RJ, Marcus JT, Faes TJ, Gan TJ, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 2005;234:710-717.
2. Bouchard A, Higgins CB, Byrd BF III, Amparo EG, Osaki L, Axelrod R. Magnetic resonance imaging in pulmonary arterial hypertension. Am J Cardiol 1985;56:938-942.
3. Katz J, Whang J, Boxt LM, Barst RJ. Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging. J Am Coll Cardiol 1993;21:1475-1481.
4. Boxt LM, Katz J, Kolb T, Czegledy FP, Barst RJ. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. J Am Coll Cardiol 1992;19:1508-1515.
5. Gan CT, Lankhaar JW, Marcus JT, Westerhof N, Marques KM, Bronzwaer JG, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2006;290:H1528- H1533.
6. Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004;147:218-223.
7. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP. Normal human right and left ventricular mass, systolic function and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7-21.
8. Vonk-Noordegraaf A, Marcus JT, Holverda S, Roseboom B, Postmus PE. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest 2005;127:1898-1903.
9. Calverley PM, Howatson R, Flenley DC, Lamb D. Clinicopathological correlations in cor pulmonale. Thorax 1992;47:494-498.
10. van Wolferen SA, Marcus JT, Boonstra A, Marques KMJ, Bronzwaer JGF, Spreeuwenberg MD, Postmus PE, Vonk-Noordegraaf A. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28: 1250-1257.
11. Saba TS, Foster J, Cockburn M, Cowan M, Peacock AJ. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J 2002;20:1519-1524.
12. Roeleveld RJ, Marcus JT, Boonstra A, Postmus PE, Marques KM, Bronzwaer JG, Vonk-Noordegraaf A. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 2005;22:67-72.
13. Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 2003;108: 2066-2069.
14. Roeleveld RJ, Vonk-Noordegraaf A, Marcus JT, Bronzwaer JG, Marques KM, Postmus PE, Boonstra A. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest 2004;125:572-579.
15. Van Wolferen SA, Boonstra A, Marcus JT, Marques KM, Bronzwaer JG, Postmus PE, Vonk-Noordegraaf A. Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension. Heart 2006;92:1860-1861.
16. Wilkins MR, Paul GA, Strange JW, Tunariu N, Gin-Sing W, Banya WA, Westwood MA, Stefanidis A, Ng LL, Pennell DJ, Mohiaddin RH, Nihoyannopoulos P, Gibbs JS. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med 2005;171:1292-1297.
17. Rebergen SA, van der Wall EE, Doornbos J, de Roos A. Magnetic resonance measurement of velocity and flow: technique, validation, and cardiovascular applications. Am Heart J 1993;126:1439-1456.
18. Fratz S, Hess J, Schwaiger M, Martinoff S, Stern HC. More accurate quantification of pulmonary blood flow by magnetic resonance imaging than by lung perfusion scintigraphy in patients with fontan circulation. Circulation 2002;106:1510-1513.
19. Beerbaum P, Korperich H, Barth P, Esdorn H, Gieseke J, Meyer H. Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation 2001;103:2476-2482.
20. Beerbaum P, Korperich H, Gieseke J, Barth P, Peuster M, Meyer H. Rapid left-to-right shunt quantification in children by phase-contrast magnetic resonance imaging. combined with sensitivity encoding (SENSE). Circulation 2003;108:1355-1361.
21. Lankhaar JW, Hofman MB, Marcus JT, Zwanenburg JJ, Faes TJ, Vonk-Noordegraaf A. Correction of phase offset errors in main pulmonary artery flow quantification. J Magn Reson Imaging 2005;22:73-79.
22. Kondo C, Caputo GR, Masui T, Foster E, O'Sullivan M, Stulbarg MS, Golden J, Catterjee K, Higgins CB. Pulmonary hypertension: pulmonary flow quantification flow profile analysis with velocity-encoded cine MR imaging. Radiology 1992;183:751-758.
23. Tardivon AA, Mousseaux E, Brenot F, Bittoun J, Jolivet O, Bourroul E, Duroux P. Quantification of hemodynamics in primary pulmonary hypertension with magnetic resonance imaging. Am J Respir Crit Care Med 1994;150:1075-1080.
24. Muthurangu V, Taylor A, Andriantsimiavona R, Hegde S, Miquel ME, Tulloh R, Baker E, Hill DLG, Razavi RS. Novel method of quantifying pulmonary vascular resistance by use of simultaneous invasive pressure monitoring and phase-contrast magnetic resonance flow. Circulation 2004;110:826- 834.
25. Bogren HG, Klipstein RH, Mohiaddin RH, Firmin DN, Underwood SR, Rees RS, Longmore DB. Pulmonary artery distensibility and blood flow patterns: a magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension. Am Heart J 1989;118:990-999.
26. Laffon E, Vallet C, Bernard V, Montaudon M, Ducassou D, Laurent F, Marthan R. A computed method for noninvasive MRI assessment of pulmonary arterial hypertension. J Appl Physiol 2004;96:463-468.
27. Gan TC, Holverda S, Marcus JT, Paulus WJ, Marques KM, Bronzwaer JGF, Twisk JW, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Right ventricular diastolic dysfunction and the acute effects of Sildenafil in pulmonary hypertension patients. Chest 2007;132:11-17.
28. Nichols K, Saouaf R, Ababneh AA, Barst RJ, Rosenbaum MS, Groch MW, Shoyeb AH, Bergmann SR. Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging. J Nucl Cardiol 2002;9:153-160.
29. Murgo JP, Westerhof N. Input impedance of the pulmonary arterial system in normal man. Effects of respiration and comparison to systemic impedance. Circ Res 1984;54:666-673.
30. Murgo JP, Westerhof N, Giolma JP, Altobelli SA. Aortic input impedance in normal man: relationship to pressure wave forms. Circulation 1980;62:105-116.
31. Westerhof N, Stergiopulos N, Noble MIM. Snapshots of Hemodynamics. Boston: Springer-Kluwer; 2005.
32. Huez S, Brimioulle S, Naeije R, Vachiery JL. Feasibility of routine pulmonary arterial impedance measurements in pulmonary hypertension. Chest 2004;125:2121-2128.
33. Laskey WK, Ferrari VA, Palevsky HI, Kussmaul WG. Pulmonary artery hemodynamics in primary pulmonary hypertension. J Am Coll Cardiol 1993;21:406-412.
34. Haneda T, Nakajima T, Shirato K, Onodera S, Takishima T. Effects of oxygen breathing on pulmonary vascular input impedance in patients with pulmonary hypertension. Chest 1983;83:520-527.
35. Westerhof N, Elzinga G, Sipkema P. An artificial arterial system for pumping hearts. J Appl Physiol 1971;31:776-781.
36. Grant BJ, Paradowski LJ. Characterization of pulmonary arterial input impedance with lumped parameter models. Am J Physiol 1987;252: H585-H593.
37. Lankhaar JW, Westerh of N, Faes TJC,Marques KM, Marcus JT, Postmus PE, Vonk-Noordegraaf A. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006;291:H1731-H1737.
38. Kuehne T, Yilmaz S, Schulze-Neick I, Wellnhofer E, Ewert P, Nagel E, Lange P. Magnetic resonance imaging guided catheterisation for assessment of pulmonary vascular resistance: in vivo validation and clinical application in patients with pulmonary hypertension. Heart 2005;91:1064-1069.
39. Bock M, Muller S, Zuehlsdorff S, Speier P, Fink C, Hallscheidt P, Umathum R, Semmler W. Active catheter tracking using parallel MRI and real-time image reconstruction. Magn Reson Med 2006;55:1454-1459.
40. Razavi R, Hill DL, Keevil SF, Miquel ME, Muthurangu V, Hegde S, Rhode K, Barnett M, van Vaals J, Hawkes PD, Baker E. Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet 2003;362:1877-1882.
41. Muthurangu V, Atkinson D, Sermesant M, Miquel ME, Hegde S, Johnson R, Andriantsimiavona R, Taylor AM, Baker E, Tulloh R, Hill DL, Razavi RS. Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR guided cardiac catheterization. Am J Physiol Heart Circ Physiol 2005;289:H1301-H1306.
42. Gaynor SL, Maniar HS, Bloch JB, Steendijk P, Moon MR. Right atrial and ventricular adaptation to chronic right ventricular pressure overload. Circulation 2005;112:I212-I218.
43. Holverda S, Gan CTJ, Marcus JT, Postmus PE, Boonstra A, Vonk-Noordegraaf A.Impaired stroke volumeresponse to exercise inpulmonary arterial hypertension. J Am Coll Cardiol 2006;47:1732-1733.
44. Murray PA, Baig H, Fishbein MC, Vatner SF. Effects of experimental right ventricular hypertrophy on myocardial blood flow in conscious dogs. J Clin Invest 1979;64:421-427.
45. Kluge R, Barthel H, Pankau H, Seese A, Schauer J, Wirtz H, Seyfarth HJ, Steinbach J, Sabri O, Winkler J. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med 2005;46:25-31.
46. Oikawa M, Kagaya Y, Otani H, Sakuma M, Demachi J, Suzuki J, Takahashi T, Nawata J, Ido T, Watanabe J, Shirato K. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 2005;45:1849-1855.
47. Gomez A, Bialostozky D, Zajarias A, Santos E, Palomar A, Martinez ML, Sandoval J. Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol 2001;38:1137-1142.
48. Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, Peacock AJ. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005;26:1993-1999.
49. Nelson GS, Sayed-Ahmed EY, Kroeker CA, Sun YH, Keurs HE, Shrive NG, Tyberg JV. Compression of interventricular septum during right ventricular pressure loading. Am J Physiol Heart Circ Physiol 2001;280:H2639- H2648.